Post-approval studies (Phase 4)Study completedNCT01171820
What this trial is testing
SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)
Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 324